Navigation Links
PharmaVentures Engaged by Astex Therapeutics to Assist in the Divestment of US Facility
Date:9/9/2011

OXFORD, England, September 9, 2011 /PRNewswire/ --

PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by leading drug discovery company, Astex Pharmaceuticals to seek a buyer for an established full service CMC (chemistry, manufacturing & controls) & Formulation Facility in Pleasanton, California. The engagement will utilise PharmaVentures' asset divestment expertise in the life sciences sector.

Dr Fintan Walton, CEO, PharmaVentures commented, "We are delighted to have been chosen by Astex to assist in divesting this state-of-the-art facility, maximising return for the stakeholders.  With 20 years' experience of transactions, PharmaVentures can provide Astex with access to key decision makers in relevant companies with a view to safeguarding the future of the site."

The facility is part of the recent integration of Astex Therapeutics Limited and SuperGen Inc. and provides an opportunity to build out a fully integrated CMC capability in a prime but low cost West Coast US location.  The site's team has significant experience in preclinical as well as Phase I, II and III drug product development as evidenced by over 30 patents and the successful oversight of a number of global regulatory filings.

PharmaVentures is a leading life sciences transaction advisory firm with strong capabilities in finding and evaluating opportunities and negotiating deals.  The transactions team has an established track record in generating outstanding value for PharmaVentures' clients and has assisted in over 100 transactions in the past 20 years.  

For enquiries regarding this opportunity or how we can help your company to achieve its business goals, please contact:

Dr Jansen Jacobs
Senior Advisor
PharmaVentures Ltd
jansen.jacobs@pharmaventures.com
+44-7951-205420


'/>"/>
SOURCE Pharma Ventures Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Matrix Corporate Capital and PharmaVentures Announce the Signing of a Memorandum of Understanding (MOU)
2. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
3. PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C.F.M. Group
4. Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM
5. CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics
6. Debiopharm and Ascenta Therapeutics, Inc. Announce An Exclusive License Agreement for the Development and Commercialization of the IAP (Inhibitor of Apoptosis Protein) Inhibitor AT-406 (Called Debio 1143 by Debiopharm) for the Treatment of Various T
7. FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech
8. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
9. PTC Therapeutics and Genzyme Announce Restructuring of Collaboration
10. Amsterdam Molecular Therapeutics Reports Half-Year Results 2011
11. Randomized Study Comparing Cell Therapeutics OPAXIO (Paclitaxel Poliglumex) and Radiotherapy to Standard of Care Temozolomide and Radiotherapy Treatment Open for Enrollment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... MA (PRWEB) May 28, 2015 ... located in Basel, Switzerland, and the Alliance ... a Cambridge, Massachusetts-based non-profit organization operating in ... a global system to enhance quality, safety, ... development and health research, are pleased to ...
(Date:5/27/2015)... DUBLIN , May 26, 2015 /PRNewswire/ ... has announced the addition of Jain PharmaBiotech,s ... Markets and Companies" to their offering. ... the molecular diagnostics technologies that will play ... public health, pharmaceutical industry, forensics and biological ...
(Date:5/27/2015)... Expanding in a big way into the Japanese ... recently inked a deal with Arthur Mokuda, president ... the largest endodontic distributor in Japan. The move represents ... Biomed, which manufactures Grey MTA Plus® and the newly ... have won renown from dentists around the world. , ...
(Date:5/27/2015)... Cambridge, MA (PRWEB) May 27, 2015 ... it is directing, via its wholly owned subsidiary, ... a potential treatment for ALS that targets the innate ... the ALS Therapy Development Institute received from the 2014 ... Challenge.” The entire sum of $4 million raised directly ...
Breaking Biology Technology:Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 3Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 2Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 3Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 3Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3
... July 15, 2011 Biocept, Inc. announced today that ... President, Finance and Chief Financial Officer.  As CFO, Mr. ... accounting, finance, treasury, investor relations, risk management and information ... leadership experience in helping to build life science companies. ...
... July 15, 2011 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, today announced that the ... to succeed John Pappajohn as Chairman of the Board. ... immediately. Dr. Sayare has been a member ...
... July 14, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... trial for BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, ... Phase 1/2 trial for BMN 673 for the treatment of ... is ongoing. "We are excited to be ...
Cached Biology Technology:Biocept, Inc. Announces New CFO 2Biocept, Inc. Announces New CFO 3Mitchel Sayare, Ph.D. to Succeed John Pappajohn as Chairman of the Company's Board of Directors 2Mitchel Sayare, Ph.D. to Succeed John Pappajohn as Chairman of the Company's Board of Directors 3BioMarin Initiates Phase 1 Trial for BMN 673 in Patients With Advanced Hematological Malignancies 2BioMarin Initiates Phase 1 Trial for BMN 673 in Patients With Advanced Hematological Malignancies 3
(Date:5/10/2015)... , May 11, 2015 Fingerprint Cards ... FPC1025 and FPC1155 from the distributor World Peace Industrial Group ... distributors in Asia . Deliveries are planned ... be used by smartphone manufacturers in China ... the communicated revenue guidance of + 1 000 MSEK for 2015. ...
(Date:4/27/2015)... , April 27, 2015  For more than ... trade show has been the premier worldwide event for ... 2015 is a must-attend event for any local, national, ... into the emerging commercial markets and current applications of ... innovations of this projected $48 billion industry, and how ...
(Date:4/20/2015)... , April 20, 2015 ...   Glenbeigh Records Management (GRM), Ireland,s ... with Dubai Islamic Bank. Having built up an impressive track ... now a leading player within the records management sector in ... expects to double is GCC staffbase and employ a further ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... turn back the biological clock and extend their lifespan ... report. Their study, published online this month in ... the old notion of a tradeoff between reproduction and ... that "the more you reproduce, the shorter you,re going ...
... Hopkins Bloomberg School of Public Health have found ... exposure to antibiotic-resistant bacteria from intensively raised poultrydriving ... to slaughterhouse. A study by the Hopkins researchers ... and drug-resistant, on surfaces and in the air ...
... Danny Reinberg was awarded a Howard Hughes Institute of ... epigenetics- helping to unravel the impact lifestyle and environment ... can teach us about aging and behavior. Results of ... humans, using gene regulation in ants as a model ...
Cached Biology News:Old flies can become young moms 2Transporting broiler chickens could spread antibiotic-resistant organisms 2Ants may help researchers unlock mysteries of human aging process 2Ants may help researchers unlock mysteries of human aging process 3
... Supercoiled DNA Ladder is ... from 2 to 16 kb ... The bands can be visualized ... may also be detected on ...
... system consists of AmnioMAX-C100 ... 17001-082) and AmnioMAX-C100 Supplement ... is complete with antibiotics ... and requires no further ...
...
... ml Dynabeads Tosylactivated (4.5 m). Hydrophobic ... For coupling of antibodies for cell applications. ... with covalent binding of primary amine groups ... occurringovernight. Coupling reactions can be performed at ...
Biology Products: